The AABB Foundation Early-Career Scientific Research Grants 2027 support investigators developing original research in transfusion medicine, blood banking and biotherapies. The program provides seed funding to generate preliminary data and support progression towards research independence.
For oncology researchers, relevant areas include stem cell transplantation, residual disease detection after transplantation, graft-versus-host disease models and novel cellular therapies. Applicants worldwide can apply, provided their work fits the program’s scientific scope.
Eligibility Criteria
- Applicants may be MDs, PhDs, medical technologists, or transfusion medicine and biotherapies professionals.
- Applicants generally must be within 10 years of completing their terminal research degree or medical residency, whichever occurred later.
- Previous recipients of substantial research grants, such as an NIH R01, are ineligible.
- Applicants must not have previously received an AABB Foundation Early-Career Scientific Research Grant.
- Research should support the applicant’s progression towards independence.
- Funding cannot supplement an already funded research project.
- Applications and supporting materials must be submitted in English.
Funding Details
- Maximum award: US $100,000 total.
- Duration: One or two years.
- Funding supports research costs; institutional overhead, travel and publication fees are excluded.
- Application fee: $160, waived for eligible AABB individual members.
Deadline
- Application deadline: December 1, 2026, at 11:59 PM Eastern Time.
- Applications for the 2027 cycle are currently open.